share_log

SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Sullivan Eddie Joe

SAB Biotherapeutics | 4:持股變動聲明-首席執行官 Sullivan Eddie Joe

SEC announcement ·  2023/12/08 08:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息